CLINICAL_TRIALS
trial_result
· 2024-10-16
Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of L608 in Healthy Adults [Phase 1]
Summary
This Phase 1 trial reports on the safety, tolerability and pharmacokinetics of L608 in healthy adults.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pharmosa Biopharm Inc. | Conditions: Pulmonary Arterial Hypertension | Phase 1 | Status: COMPLETED